Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_assertion type Assertion NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_head.
- NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_assertion description "[We also found the E33SNP C/C genotype of the Tg gene was strongly associated with a subgroup of GD patients who were also characterized as having a higher relapse rate, significantly higher levels of persisting TSH-receptor antibody at the end of treatment, a higher frequency in smoking, and a higher incidence of ophthalmopathy (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_provenance.
- NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_assertion evidence source_evidence_literature NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_provenance.
- NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_assertion SIO_000772 17550957 NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_provenance.
- NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_assertion wasDerivedFrom befree-20150227 NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_provenance.
- NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_assertion wasGeneratedBy ECO_0000203 NP730772.RAThJIk3gdAfO3gwX-PkJ0ElQfCMSSt1gJbmb3CxMvbnU130_provenance.